On Air Now

Listen

Listen Live Now » 95.5 FM Wausau, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
53° Feels Like: 53°
Wind: NW 0 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Showers 47°

Tomorrow

AM Showers 67°

Tues Night

Partly Cloudy 33°

Alerts

Novartis says study shows Gilenya benefits patients with MS

A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash
A Novartis logo is pictured on its headquarters building in Mumbai April 1, 2013. REUTERS/Vivek Prakash

ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease.

The Basel-based pharmaceutical manufacturer is relying on new products like Gilenya to offset patent expiries of key drugs such as Diovan for high blood pressure.

Switching to Gilenya from interferon increased the proportion of patients disease free after one year of treatment, Novartis said on Wednesday.

(Reporting by Alice Baghdjian)

Comments